alexa Huan Xie | College of Pharmacy and Health Sciences
ISSN: 2157-7439

Journal of Nanomedicine & Nanotechnology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 

Huan Xie

Huan Xie Huan Xie
Associate Professor
Department of Pharmaceutical Sciences
College of Pharmacy and Health Sciences
USA
 
 
Biography

Huan Xie, PhD is an Associate Professor at Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences. She has a broad background in nano- formulation and targeted drug delivery, with specific focus and expertise in cancer therapy applications. Dr. Xie had over 3-year industrial working experience at Nanospectra Biosciences, Inc., contributing the development of silica/gold nanoshells for photothermal ablation cancer therapy. Now this product is in several clinical trials, becoming one of the very few metal nanoparticle-based systems ever approved by FDA. Dr. Xie joined TSU in 2008 and further applied her expertise in nanodrug formulation and delivery area. She has obtained several prestigious funding awards ever since then, including the prestigious PhRMA grant at 2010, which only awards to two pharmaceutical recipients each year nation-wide; a NIH-RTRN grant at 2011; and NIH-SC3 grant at 2012, which is a four-year close to half million grant. She published over 20 papers and book chapters and is inventor of 1 pending patent. She has delivered over 50 presentations at various international conferences and academic institutions. She received “Minority-serving Institution Faculty Scholar in Cancer Research Award” from American Association for Cancer Research in 2012. Dr. Xie currently is the Director of TSU RCMI Pharmacology core. She served on TSU University Research Advisory Council, University Rank, Tenure, Promotion and Salary Committee, as well as TSU IACUC committee. In addition, she served on editorial board of several journals and is an active reviewer for numerous journals.

Research Interest

I have a broad background in drug formulation, drug delivery, pharmacokinetics and nanotechnology, with specific training, expertise, leadership and motivation to serve as Director of the RCMI Pharmacology Core. After I received my Ph.D. at North Carolina State University with focus on nano-conjugation and intracellular targeting, I became a Senior Research Scientist at Nanospectra Biosciences, Inc., where I worked on silica/gold nanoshells for photothermal ablation cancer therapy for 4 years. And now this product is in several cancer clinical trials. Since I joined Texas Southern University in 2008, I further applied my expertise to my research. In addition to my normal teaching load, I have successfully carried out over 10 research projects, taught over 700 Pharm.D. students and personally mentored over 20 Ph.D., Pharm.D., and undergraduate students as well as collaborated with various researchers from universities and companies across the nation. As PI or co-Investigator on several NIH- and private agent- funded grants, I laid the groundwork for the proposed research by developing novel analytical methods, advanced drug formulations and drug delivery systems, and establishing their pharmacokinetic and biodistribution profiles, as documented in the following publications. In addition, I successfully administered the projects (e.g. staffing, research protections, budget), collaborated with other researchers, and produced several peer-reviewed publications from each project. As a result of these previous experiences, I am aware of the importance of frequent communication among project members and of constructing a realistic research plan, timeline, and budget. The current application builds logically on my prior work.

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version